Purpose To assess diagnostic performance of quantitative ultrasound (QUS) biomarkers in
assessing hepatic steatosis. Methods We prospectively recruited 125 participants (mean …

AIM: To establish and validate a simple quantitative assessment method for nonalcoholic
fatty liver disease (NAFLD) based on a combination of the ultrasound hepatic/renal ratio and …

OBJECTIVE. The purpose of this study is to explore the diagnostic performance of two
investigational quantitative ultrasound (QUS) parameters, attenuation coefficient and …

Ultrasound Attenuation Imaging vs MRI-PDFF, Echogenicity and... : Ultrasound Quarterly
Ultrasound Attenuation Imaging vs MRI-PDFF, Echogenicity and Liver Function for Assessing …

Objectives Steatosis, nonalcoholic steatohepatitis (NASH), and fibrosis/cirrhosis represent a
spectrum of fatty liver disease. The ultrasound fatty liver indicator (US‐FLI) evaluates …

Rationale and Objectives Marked liver steatosis, steatohepatitis, and significant fibrosis are
risk factors for unfavorable outcomes in non-alcoholic fatty liver disease (NAFLD). In this …

Purpose To investigate the correlation between different ultrasound attenuation-based
techniques and to compare their diagnostic performances using proton magnetic resonance …

Nonalcoholic fatty liver disease (NAFLD) is entering a new era in terms of diagnosis and
conceptualization. The term NAFLD is considered to not reflect current knowledge …

Objectives Nonalcoholic fatty liver disease (NAFLD) is the most widespread chronic liver
disease type in the Western countries. Ultrasound (US) is used for NAFLD and hepatic …

Background Hepatic steatosis is a condition frequently encountered in clinical practice, with
potential progression towards fibrosis, cirrhosis, and hepatocellular carcinoma. Detection …